ALEC
Alector IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$245.37M
P/E Ratio
—
EPS
$-1.19
Beta
0.65
52W High
$3.40
52W Low
$1.09
50-Day MA
$2.30
200-Day MA
$2.12
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
8.47
PEG Ratio
—
About Alector Inc
Alector, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of neurodegenerative diseases. The company is headquartered in South San Francisco, California.
Fundamentals
| Revenue (TTM) | $18.42M |
| Gross Profit (TTM) | $-88.86M |
| EBITDA | $-127.49M |
| Operating Margin | -2382.00% |
| Return on Equity | -238.90% |
| Return on Assets | -25.70% |
| Revenue/Share (TTM) | $0.17 |
| Book Value | $0.09 |
| Price-to-Book | 23.74 |
| Price-to-Sales (TTM) | 13.32 |
| EV/Revenue | 4.046 |
| EV/EBITDA | -8.40 |
| Quarterly Earnings Growth (YoY) | -86.30% |
| Quarterly Revenue Growth (YoY) | -71.50% |
| Shares Outstanding | $111.03M |
| Float | $94.09M |
| % Insiders | 9.57% |
| % Institutions | 84.06% |
Historical Volatility
HV 10-Day
61.91%
HV 20-Day
78.49%
HV 30-Day
76.17%
HV 60-Day
81.55%
HV Rank
—
Volatility is currently contracting
Analyst Ratings
Consensus ($3.10 target)
3
Buy3
Hold1
Sell1
Strong SellMore HEALTHCARE Stocks
Data last updated: 5/25/2026